Results 121 to 130 of about 396,951 (299)

Rapid Onset Acute Epiglottitis Leading to Negative Pressure Pulmonary Edema

open access: yesIndian Journal of Anaesthesia, 2007
Pulmonary edema is a potentially life-threatening complication of acute airway obstruction. It develops rapidly, without warning, in young healthy individuals.
V Saraswat, P V Madhu, Suresh S Kumar
doaj  

Does the airway circulation influence airflow obstruction in asthma? [PDF]

open access: yes
The airway wall is thickened in asthma and the airway microvasculature participates in the remodelling. It has been assumed but not convincingly demonstrated that the remodelled airway vasculature has a mechanical role in asthma-associated airflow ...
Wanner, Adam, Adam Wanner
core   +1 more source

Inflammatory Signatures Beyond Th1/Th2 Endotypes Provide Insights Into Postoperative Recurrence in Chronic Rhinosinusitis

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis (CRS) represents a spectrum of inflammatory endotypes, driven by distinct T helper (Th) immune responses. The high rate of recurrent disease despite appropriate medical and surgical interventions highlights the need for improved characterization beyond the traditional type 2 and non‐type 2 phenotypes to better
Liyona Kampel   +9 more
wiley   +1 more source

Clinical Longitudinal Evaluation After Regimen Stop (CLEAR) of Dupilumab in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Long‐term management strategies for severe chronic rhinosinusitis with nasal polyps (CRSwNP) increasingly include biologic therapy targeting Type 2 inflammation. However, data on outcomes after complete discontinuation of dupilumab following sustained disease control are scarce.
Patrick Huber   +7 more
wiley   +1 more source

Biologics Adoption in CRSwNP and the Associated Decline in Endoscopic Sinus Surgery: A Longitudinal Claims Database Study

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Biologic treatments were introduced for chronic rhinosinusitis with nasal polyps (CRSwNP) in 2019. Treatment algorithms for medically refractory CRSwNP remain open, with patients choosing among surgery, biologics, or both. Real‐world utilization of surgery and biologics remains incompletely characterized.
Stephanie Shintani Smith   +5 more
wiley   +1 more source

Airway

open access: yes, 2013
Airway obstructionComplications at intubationAirway/facial traumaAirway/facial burnsAirway infectionsAirway foreign bodiesAirway haemorrhageEndotracheal tube complicationsTracheostomy complicationsAn obstructed airway is a medical emergency requiring ...
Ravi Mahajan   +2 more
core   +1 more source

Poly(I:C)‐Activated Nasal Fibroblasts Promote Eosinophil Recruitment in CRSwNP

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by persistent mucosal inflammation and eosinophilic infiltration. Although epithelial and immune cells have been widely studied, the role of nasal fibroblasts in innate immune activation and eosinophil recruitment remains unclear.
Chaewon Shin   +5 more
wiley   +1 more source

Pathophysiology of upper airway obstruction during sleep.

open access: yes, 2002
The obstructive sleep apnoea syndrome (OSAS) is characterised by repetitive upper airway obstructions leading to snoring, hypopnoeas and apnoeas. Sleep fragmentation and arterial oxygen desaturations are the first consequences. Since the discovery of the
Liistro, Giuseppe
core  

Airway glycoprotein secretion parallels production and predicts airway obstruction in pulmonary allergy

open access: yes, 2004
Background: Airway obstruction, perhaps the most relevant clinical feature of asthma, is typically assessed in allergic asthma models as airway hyperresponsiveness. Excess secretion of airway glycoproteins also contributes to airway obstruction in asthma
Xu M   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy